Health·2,849 stories
Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
Scripps researchers identified that a chemical modification of the STING protein drives chronic brain inflammation in Alzheimer’s disease. Blocking this switch in mice reduced inflammation and protect
A new study from Fox Chase Cancer Center shows that melanoma metastasis is lowest in young mice, spikes in middle‑aged mice, and falls again in very old mice. The pattern links to a decline in protect
The U.S. military conducted a Saturday strike on an alleged drug‑smuggling boat in the eastern Pacific, killing three men and raising the campaign’s death toll to 205 in a month‑long operation.
A 500‑patient trial of the KRAS‑targeting pill daraxonrasib showed metastatic pancreatic cancer patients lived an average of 13.2 months—about twice as long as those on chemotherapy—while experiencing
A pivotal trial of Revolution Medicines’ KRAS‑G12C inhibitor daraxonrasib showed pancreatic cancer patients lived nearly twice as long as those on standard chemotherapy, a result hailed as practice‑ch
A Phase 3 PROTEUS trial showed that giving high‑risk prostate cancer patients two hormone drugs before and after prostatectomy outperforms the standard single‑drug regimen. The findings, hailed as a “
A Chinese‑run trial of ivonescimab, a dual‑action lung‑cancer drug, cut death risk by 34% in squamous non‑small cell patients, far surpassing standard therapy. The results, unveiled at ASCO and publis
Losing weight may involve rewiring the gut and the brain at the same time
Turkey’s hair‑transplant sector has become a $3 billion engine of medical tourism, driven by cheap, high‑volume procedures that rely on hacked equipment and algorithmic methods. The boom fuels cultura
A Brazilian‑funded study showed that fish oil supplementation reduces insulin resistance, improves blood sugar control, and lowers cholesterol in non‑obese type 2 diabetes rats. The findings highlight
At the ASCO meeting, BioNTech and Pfizer unveiled new bispecific antibody data, while FDA official Rick Pazdur framed the agency’s current challenges as a chance to restructure. The juxtaposition high
A triple‑action cancer jab, amivantamab, showed dramatic tumor shrinkage and complete eradication in a multinational trial of patients with resistant head‑neck cancer. The subcutaneous therapy, develo
Former FDA oncology chief Rick Pazdur warned that Trump‑era appointees caused extensive damage to the agency, but he sees the fallout as a rare chance to rebuild the FDA from the ground up. He propose
Revolution Medicines has begun delivering its experimental pancreatic‑cancer drug daraxonrasib to patients under an FDA‑authorized early‑access program. The drug, not yet approved, showed in a Phase 3
A massive NHS trial of Grail’s Galleri multi‑cancer blood test, involving nearly 143 k asymptomatic adults, failed to cut late‑stage cancer diagnoses, missing its primary endpoint. While the test show
While SKIMNEWS has been tracking Meta’s AI push on Threads and Strategy’s $1.5 billion convertible‑debt retirement, a new BMJ‑published trial shows that a modest melatonin supplement can boost DNA rep
Amid high‑stakes diplomatic moves, a massive legal battle, and a $10 B+ weekly funding request, Trump’s latest medical memo says he’s in excellent health but needs to shed weight and exercise more. Th
A 'blue micromoon' rises on May 31 — the month's second full moon, also coinciding with the moon's farthest orbital point. Despite the name, the moon won't appear blue, and UK viewers won't see this c
Canadian entrepreneur Cathy Tie—dubbed “Biotech Barbie”—is launching a venture‑backed startup to edit embryos for disease prevention, promising transparent, regulator‑approved work after a high‑profil
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.